Coherent Market Insights published a business research report on Plasma Therapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2022–2028. Plasma Therapy Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4155
During an H1N1 virus outbreak, the impact of plasma therapy on patients was studied. The treatment decreased respiratory difficulties and reduced mortality. The study found that 98.5% of patients treated with plasma therapy recovered and were discharged within 22 days. The study included 93 COVID-19 infected individuals, of whom 20 received plasma therapy. The treatment group experienced a lower mortality rate than the control group. Here are the benefits of plasma therapy.
In addition to reducing hospital stays, plasma therapy has many other benefits. It is an effective means of treating patients with various infections, and can increase immune system functioning. The treatment is effective in preventing bacterial and viral complications. This form of treatment can also reduce the risk of infection. Although the benefits of plasma therapy are clear, more research is needed to determine the optimal dosage and duration for each patient
Global Plasma Therapy Market – Impact of the Coronavirus (COVID – 19) Pandemic
On 24th August 2020, the Food and Drug Administration (U.S. FDA) approved the Convalescent plasma therapy for treatment of Covid – 19 patients in the U.S., without completing the clinical trial due to the exponential increase in the coronavirus infected patients. Convalescent plasma therapy uses blood from people who’ve recovered from the coronavirus infection to help others recover. On 3rd June 2020, researchers from the Houston Methodist Hospital in the U.S. initiated clinical trials for recording efficacy of the plasma therapy when plasma is transfused from recovered Covid-19 patients into critically ill patients. According to the researchers, 19 out of 25 patients were showing signs of recovery post plasma therapy and 11 patients were later discharged from the hospital following recovery.
Furthermore, many organizations are involved in increasing awareness about donation of plasma. Therefore, the global plasma therapy market is expected to witness growth due to the lack of an appropriate proper vaccine or drug for the treatment of Covid – 19 patients.
The global plasma therapy market is estimated to be valued at US$ 226.13 million in 2020 and is expected to exhibit a CAGR of 14.1% during the forecast period (2020-2027).
Key players are adopting inorganic activities such as collaborations to develop new treatment plans for patients suffering from the coronavirus
For instance, on 7th April 2020, Takeda and CSL Behring collaboratively developed a new treatment for patients suffering from the coronavirus infection. The treatment plan involves using blood plasma of patients who have recovered from the infection by further isolating the antibodies from the plasma and injecting it in patients. This therapy triggers an immune response in the body of the patients which can help them survive the infection.
New Product launches are projected to drive growth of the global plasma therapy market during the forecast period.
For instance, in 2019, Adimarket, LLC, a subsidiary of the Global Stem Cells Group, launched platelet rich plasma (PRP). PRP is a new treatment option in regenerative medicine. Adimarket, LLC, will provide the PRP kit to physicians along with the treatment protocol, so that patients requiring critical aesthetic, wound and orthopedic care can receive affordable and easy treatment.
Global Plasma Therapy Market – Restraints
The absence of compensation policies as well as high cost of the plasma therapy treatment are projected to hinder the global plasma therapy market growth over the forecast period.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4155
Global Plasma Therapy Market – Regional Analysis
Companies in North America are focused on inorganic strategies such as collaborations and partnerships to increase the supply of plasma to processing centers and ensuring that a treatment option is available for rare and serious disorders. For instance, in 2017, KEDPLASMA LLC, a subsidiary of Kedrion Biopharma Inc. entered a plasma supply agreement with ImmunoTek Bio Centers, LLC, in which, the ImmunoTek Bio Centers, LLC, developed a total of 28 plasma collection centers for Kedplasma LLC in the U.S. Kedplasma will use the plasma to manufacture different plasma therapies for rare and chronic disorders. Such factors are projected to drive the plasma therapy market growth in North America.
Governments in Asia–Pacific are involved in research and development of new treatments for COVID-19. For instance, on 30th June 2020, the government of Maharashtra, a state in India, launched Platina, one of the largest trials across the globe for treatment of COVID-19 patients. The project aims to provide free plasma therapy at 21 government centers in Maharashtra to increase the chances of survival of the infected patients. The government is also spreading awareness among recovered patients regarding plasma donation so that the plasma can be processed and utilized for therapy. Such projects are expected to boost the global plasma therapy market growth during the forecast period.
Global Plasma Therapy Market – Competitive Landscape
Octapharma AG, China Biologic Products Holdings, Inc. Bio Products Laboratory Ltd, Kedrion S.p.A , Grifols, S.A., CSL, Biotest AG., Takeda Pharmaceutical Company Limited., DePuy Synthes, Regen Lab SA, LFB SA., and Immunotek Bio Centers
Buy This Report With USD 2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/4155
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Plasma Therapy Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Plasma Therapy Industry Impact
Chapter 2 Global Plasma Therapy Competition by Types, Applications, and Top Regions and Countries
2.1 Global Plasma Therapy (Volume and Value) by Type
2.3 Global Plasma Therapy (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Plasma Therapy Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Plasma Therapy Market Analysis
Chapter 6 East Asia Plasma Therapy Market Analysis
Chapter 7 Europe Plasma Therapy Market Analysis
Chapter 8 South Asia Plasma Therapy Market Analysis
Chapter 9 Southeast Asia Plasma Therapy Market Analysis
Chapter 10 Middle East Plasma Therapy Market Analysis
Chapter 11 Africa Plasma Therapy Market Analysis
Chapter 12 Oceania Plasma Therapy Market Analysis
Chapter 13 South America Plasma Therapy Market Analysis
Chapter 14 Company Profiles and Key Figures in Plasma Therapy Business
Chapter 15 Global Plasma Therapy Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027